Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases

S Wang, B Liang, W Wang, L Li, N Feng… - Signal transduction and …, 2023 - nature.com
Human diseases, particularly infectious diseases and cancers, pose unprecedented
challenges to public health security and the global economy. The development and …

Future cancer research priorities in the USA: a Lancet Oncology Commission

EM Jaffee, C Van Dang, DB Agus… - The Lancet …, 2017 - thelancet.com
We are in the midst of a technological revolution that is providing new insights into human
biology and cancer. In this era of big data, we are amassing large amounts of information …

[PDF][PDF] MicroRNA‐29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression

JH Fang, HC Zhou, C Zeng, J Yang, Y Liu… - …, 2011 - Wiley Online Library
Hepatocellular carcinoma (HCC) is a highly vascularized tumor with frequent intrahepatic
metastasis. Active angiogenesis and metastasis are responsible for rapid recurrence and …

Measles virus as an oncolytic immunotherapy

CE Engeland, G Ungerechts - Cancers, 2021 - mdpi.com
Simple Summary Measles virus is currently under investigation as an innovative cancer
treatment. The virus selectively replicates in and kills cancer cells. Furthermore, it can be …

Clinical trials with oncolytic measles virus: current status and future prospects

P Msaouel, M Opyrchal, A Dispenzieri… - Current cancer drug …, 2018 - benthamdirect.com
Attenuated Edmonston lineage measles virus (MV-Edm) vaccine strains can preferentially
infect and lyse a wide variety of cancer cells. Oncolytic MV-Edm derivatives are genetically …

Measles to the rescue: a review of oncolytic measles virus

S Aref, K Bailey, A Fielding - Viruses, 2016 - mdpi.com
Oncolytic virotherapeutic agents are likely to become serious contenders in cancer
treatment. The vaccine strain of measles virus is an agent with an impressive range of …

Harnessing protease activity to improve cancer care

JS Dudani, AD Warren, SN Bhatia - Annual review of cancer …, 2018 - annualreviews.org
Proteolysis plays critical roles in normal and pathologic physiology; these enzymes are
intricately involved in cancer progression and spread. Our understanding of protease …

Engineering and combining oncolytic measles virus for cancer therapy

MF Leber, S Neault, E Jirovec, R Barkley, A Said… - Cytokine & growth factor …, 2020 - Elsevier
Cancer immunotherapy using tumor-selective, oncolytic viruses is an emerging therapeutic
option for solid and hematologic malignancies. A considerable variety of viruses ranging …

Proteases in cancer drug delivery

J Vandooren, G Opdenakker, PM Loadman… - Advanced Drug Delivery …, 2016 - Elsevier
Whereas protease inhibitors have been developed successfully against hypertension and
viral infections, they have failed thus far as cancer drugs. With advances in cancer profiling …

Oncolysis by paramyxoviruses: multiple mechanisms contribute to therapeutic efficiency

OV Matveeva, ZS Guo, SA Shabalina… - Molecular Therapy …, 2015 - cell.com
Oncolytic paramyxoviruses include some strains of Measles, Mumps, Newcastle disease,
and Sendai viruses. All these viruses are well equipped for promoting highly specific and …